UNC13C
Summary:
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| unc-13 homolog C | MIM:614568 | Ensembl:ENSG00000137766 | HGNC:HGNC:23149 | PA134870087 | 15q21.3 |
GO terms in UNC13C
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| MF | IEA | GO:0005509 | calcium ion binding |
| MF | IBA | GO:0005516 | calmodulin binding |
| MF | IEA | GO:0005543 | phospholipid binding |
| MF | IBA | GO:0017075 | syntaxin-1 binding |
| MF | IEA | GO:0019992 | diacylglycerol binding |
| BP | ISS | GO:0007268 | chemical synaptic transmission |
| BP | IBA | GO:0007528 | neuromuscular junction development |
| BP | IBA | GO:0016081 | synaptic vesicle docking |
| BP | IBA | GO:0016082 | synaptic vesicle priming |
| BP | IBA | GO:0016188 | synaptic vesicle maturation |
| BP | IEA | GO:0031914 | negative regulation of synaptic plasticity |
| BP | IBA | GO:0035249 | synaptic transmission, glutamatergic |
| BP | IEA | GO:0035556 | intracellular signal transduction |
| BP | IBA | GO:0061789 | dense core granule priming |
| BP | IBA | GO:0099525 | presynaptic dense core vesicle exocytosis |
| CC | IEA | GO:0005737 | cytoplasm |
| CC | IBA | GO:0005886 | plasma membrane |
| CC | ISS | GO:0005886 | plasma membrane |
| CC | IEA | GO:0030054 | cell junction |
| CC | IBA | GO:0030672 | synaptic vesicle membrane |
| CC | IBA | GO:0031594 | neuromuscular junction |
| CC | IBA | GO:0042734 | presynaptic membrane |
| CC | IEA | GO:0042734 | presynaptic membrane |
| CC | IBA | GO:0043195 | terminal bouton |
| CC | IEA | GO:0044305 | calyx of Held |
| CC | IBA | GO:0048786 | presynaptic active zone |
| CC | TAS | GO:0048786 | presynaptic active zone |
| CC | IBA | GO:0098831 | presynaptic active zone cytoplasmic component |
Gene expression in normal tissue: UNC13C
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in UNC13C
| Database | Pathway ID | Pathway Des. |
|---|---|---|
| kegg | hsa04721 | Synaptic vesicle cycle - Homo sapiens (human) |
| wikipathways | WP2267 | Synaptic Vesicle Pathway |
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD494 | Neopeltolide | 2 |
| iGMDRD781 | Sirolimus | 4 |
| iGMDRD427 | ABT737 | 6 |
| iGMDRD546 | BMS-754807 | 2 |
| iGMDRD670 | ML 210 | 2 |
| iGMDRD420 | Leucascandrolide A | 5 |
| iGMDRD1008 | SR-II-138A | 5 |
| iGMDRD772 | BRD4770 | 3 |
| iGMDRD151 | CHM-1 | 3 |
| iGMDRD554 | CHEMBL1434137 | 3 |
| iGMDRD433 | Lexibulin | 2 |
| iGMDRD718 | Pyrvinium pamoate | 4 |
| iGMDRD639 | YK 4-279 | 2 |
| iGMDRD61 | Kinetin riboside | 3 |
| iGMDRD193 | Fqi1 | 2 |
| iGMDRD446 | LY 2183240 | 3 |
| iGMDRD201 | SKI II | 5 |
| iGMDRD318 | PAC-1 | 2 |
| iGMDRD801 | 2,4-dideoxy-DC-45-A2 | 2 |
| iGMDRD782 | DC-45-A2 | 6 |
| iGMDRD260 | FQI-2 | 3 |
| iGMDRD138 | PX 12 | 4 |
| iGMDRD524 | ISX-9 | 3 |
| iGMDRD690 | PRIMA-1MET | 2 |
| iGMDRD60 | Quinoclamine | 2 |
| iGMDRD64 | Parbendazole | 3 |
| iGMDRD577 | BIX01294 | 5 |
| iGMDRD562 | Navitoclax | 4 |
| iGMDRD188 | Piperlongumine | 2 |
| iGMDRD399 | Selumetinib | 4 |
| iGMDRD79 | Gemcitabine | 6 |
| iGMDRD560 | MK-2206 | 3 |
| iGMDRD116 | CD437 | 2 |
| iGMDRD532 | Olaparib | 3 |
| iGMDRD512 | nutlin 3 | 3 |
| iGMDRD84 | Lovastatin acid | 3 |
| iGMDRD307 | Manumycin A | 5 |
| iGMDRD123 | Isoevodiamine | 2 |
| iGMDRD177 | Teniposide | 8 |
| iGMDRD351 | GW843682X | 2 |
| iGMDRD237 | ABT-751 | 1 |
| iGMDRD415 | LE-135 | 3 |
| iGMDRD267 | Oligomycin A | 2 |
| iGMDRD231 | Importazole | 1 |
| iGMDRD289 | Parthenolide | 2 |
| iGMDRD105 | Triptolide | 1 |
| iGMDRD705 | Nakiterpiosin | 2 |
| iGMDRD434 | BMS-536924 | 2 |
| iGMDRD103 | SN-38 | 5 |
| iGMDRD202 | Curcumin | 7 |
| iGMDRD158 | NSC141540 | 7 |
| iGMDRD137 | Indisulam | 2 |
| iGMDRD82 | Quiflapon | 3 |
| iGMDRD505 | Pevonedistat | 5 |
| iGMDRD246 | NPC26 | 5 |
| iGMDRD329 | Merck60 | 4 |
| iGMDRD414 | MST-312 | 2 |
| iGMDRD872 | BRD7137 | 2 |
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in UNC13C

